Testing version — LOERadar is in active testing. Features and data may change.
WELTRUZA (OLANZAPINE) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
WELTRUZA
NDANot in Orange Book
OLANZAPINE | N219007 | TEVA NEUROSCIENCE INC
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov